Good to know that the current SP weakness has nothing to do with trial failures. The 7M sold by Aruda could be absorbed by longs. If not, it'll be easily absorbed by institutions after uplist.

We are fortunately to have a true long like you to explain the law of supply and demand to us. Really, we are.